B Hampel

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study

Robert Wilson, Tobias Welte, Eva Polverino et al. · European Respiratory Journal · 2012 · 202 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults

R. Siegert, P Géhanno, Paul Nikolaidis et al. · Respiratory Medicine · 2000 · 95 citations · Full text

Medicine, Infectious Diseases, Pharmacology +12

Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging

DAVID A. RICHARD, Sanda Nousia‐Arvanitakis, Veronika Sollich et al. · The Pediatric Infectious Disease Journal · 1997 · 67 citations

Pharmacy, Pediatrics, Pharmacotherapy +12

Comparative Pharmacokinetics of Ceftriaxone after Subcutaneous and Intravenous Administration

Klaus Borner, H. Lode, B Hampel et al. · Chemotherapy · 2009 · 66 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study

P. Judlin, Qinping Liao, Z Liu et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2010 · 63 citations

Pharmacy, Pharmacology, Pharmacotherapy +11